AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25769535 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical simulator training (n = 8)
Number of subjects: 14
Study 25769535 — intervention group
Group type: COMPARATOR
Intervention: Didactic training (n = 6)
Number of subjects: 14
Study 23680854 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-guided CBT
Number of subjects: 495
Study 23680854 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-guided psychodynamic therapy
Number of subjects: 495
Study 23680854 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 495
Study 20113526 — intervention group
Group type: EXPERIMENTAL
Intervention: Snoezelen therapy
Number of subjects: 360
Study 20113526 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured reminiscence therapy
Number of subjects: 360
Study 20113526 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-minutes activation
Number of subjects: 360
Study 20113526 — intervention group
Group type: COMPARATOR
Intervention: Unstructured verbal communication
Number of subjects: 360
Study 18221329 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise countermeasure during bed rest
Number of subjects: 16
Study 18221329 — intervention group
Group type: COMPARATOR
Intervention: Bed rest-only
Number of subjects: 16
Study 16614415 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g sesame seed powder daily for 5 weeks
Number of subjects: 26
Study 16614415 — intervention group
Group type: COMPARATOR
Intervention: Rice powder placebo for 5 weeks
Number of subjects: 26
Study 14516214 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition test (Test 1)
Number of subjects: 0
Study 14516214 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate questions on Test 2
Number of subjects: 0
Study 14516214 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-test procedure
Number of subjects: 0
Study 14516214 — intervention group
Group type: EXPERIMENTAL
Intervention: Process dissociation and remember-know procedures
Number of subjects: 0
Study 14516214 — intervention group
Group type: EXPERIMENTAL
Intervention: Order of information access
Number of subjects: 0
Study 11129729 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (Taxol) at escalating doses starting from 100 mg/m2 up to 250 mg/m2; Cremophor EL starting dose of 8.3 ml/m2 with increments of 2.1 ml/m2; Carboplatin dosages of 300, 350, or 400 mg/m2.
Number of subjects: 39
Study 8793497 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH analogue (goserelin) + oral contraceptive (OC) containing ethinyl estradiol and cyproterone acetate
Number of subjects: 0
Study 8793497 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive (OC) containing ethinyl estradiol and cyproterone acetate
Number of subjects: 0
Study 1546145 — intervention group
Group type: EXPERIMENTAL
Intervention: moclobemide 150-150-150 mg
Number of subjects: 12
Study 1546145 — intervention group
Group type: EXPERIMENTAL
Intervention: toloxatone 400-200-400 mg
Number of subjects: 12
Study 1546145 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol 50 mg
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol 100 mg
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol 200 mg
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 4 mg
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 8 mg
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 16 mg
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 102
Study 3987183 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood improvement and overall satisfaction
Number of subjects: 102
Study 31609297 — intervention group
Group type: EXPERIMENTAL
Intervention: EX (exercise)
Number of subjects: 17
Study 31609297 — intervention group
Group type: EXPERIMENTAL
Intervention: EX+CO2 (exercise + hypercapnic gas)
Number of subjects: 17
Study 29709732 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Threshold Intervention (LTI)
Number of subjects: 212
Study 29709732 — intervention group
Group type: EXPERIMENTAL
Intervention: Voucher Reinforcement Intervention (VRI)
Number of subjects: 212
Study 29709732 — intervention group
Group type: COMPARATOR
Intervention: Standard Care Intervention (SCI)
Number of subjects: 212
Study 26268482 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-SES (sirolimus eluting stent with bioresorbable polymer)
Number of subjects: 194
Study 26268482 — intervention group
Group type: COMPARATOR
Intervention: PP-EES (everolimus eluting stent with permanent polymer)
Number of subjects: 194
Study 26268482 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-SES
Number of subjects: 194
Study 26268482 — intervention group
Group type: COMPARATOR
Intervention: PP-EES
Number of subjects: 194
Study 24875810 — intervention group
Group type: EXPERIMENTAL
Intervention: Buttressed stapler (B group)
Number of subjects: 76
Study 24875810 — intervention group
Group type: COMPARATOR
Intervention: Non-buttressed stapler (non-B group)
Number of subjects: 76
Study 22184720 — intervention group
Group type: EXPERIMENTAL
Intervention: Maggot debridement therapy (MDT)
Number of subjects: 119
Study 22184720 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 119
Study 20676860 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lanolin ointment (PureLan)
Number of subjects: 71
Study 20676860 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine type I collagen spray (Gelfix)
Number of subjects: 71
Study 20676860 — intervention group
Group type: COMPARATOR
Intervention: Control group (no topical treatment)
Number of subjects: 71
Study 18565251 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) injections (3 injections with one-week interval)
Number of subjects: 30
Study 18565251 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (6 weeks)
Number of subjects: 30
Study 16006900 — intervention group
Group type: EXPERIMENTAL
Intervention: Buscopan
Number of subjects: 178
Study 16006900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study 12236885 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% 2-dimethylaminoethanol (DMAE) gel
Number of subjects: 30
Study 12236885 — intervention group
Group type: COMPARATOR
Intervention: Control formulation without DMAE
Number of subjects: 30
Study 10379746 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral varicocelectomy
Number of subjects: 91
Study 10379746 — intervention group
Group type: COMPARATOR
Intervention: Unilateral varicocelectomy
Number of subjects: 91
Study 7536438 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 100 U (group A)
Number of subjects: 0
Study 7536438 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 5000 U (group B)
Number of subjects: 0
Study 7536438 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 100 U daily for 5 days (group C)
Number of subjects: 0
Study 7536438 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (100 U and 5000 U, single injections; 100 U, multiple injections)
Number of subjects: 0
Study 7536438 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 1665184 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril-hydrochlorothiazide (L/HCTZ) 20 mg/12.5 mg
Number of subjects: 278
Study 6752873 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirprofen (1000 mg/day)
Number of subjects: 104
Study 6752873 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (125 mg/day)
Number of subjects: 104
Study 6752873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 30597541 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104
Study 30597541 — intervention group
Group type: COMPARATOR
Intervention: No disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104
Study 30597541 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104
Study 30597541 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104
Study 28600154 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure group
Number of subjects: 1071
Study 28600154 — intervention group
Group type: COMPARATOR
Intervention: Surfactant group
Number of subjects: 1071
Study 28600154 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful extubation
Number of subjects: 1071
Study 28600154 — intervention group
Group type: EXPERIMENTAL
Intervention: Failed extubation
Number of subjects: 1071
Study 27023596 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderberry extract (Sambucus nigra L.)
Number of subjects: 312
Study 27023596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 25189288 — intervention group
Group type: EXPERIMENTAL
Intervention: Repositioning every 2 hours
Number of subjects: 329
Study 25189288 — intervention group
Group type: COMPARATOR
Intervention: Repositioning every 4 hours
Number of subjects: 329
Study 21039353 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroprocaine 40 mg (20 mg/ml)
Number of subjects: 78
Study 21039353 — intervention group
Group type: COMPARATOR
Intervention: Articaine 60 mg (40 mg/ml)
Number of subjects: 78
Study 19897500 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular (LV) apical pacing
Number of subjects: 32
Study 19897500 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular (RV) apical pacing
Number of subjects: 32
Study 19897500 — intervention group
Group type: EXPERIMENTAL
Intervention: RV free wall pacing
Number of subjects: 32
Study 17392739 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5 mg hydrocortisone (cortisol)
Number of subjects: 30
Study 17392739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 14760661 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 ml of an iso-osmolar 12.5 percent carbohydrate-rich beverage (100 g carbohydrate) the evening before operation and another 400 ml (50 g carbohydrate) 2 hours before anaesthesia.
Number of subjects: 94
Study 14760661 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (same volume as the intervention).
Number of subjects: 94
Study 11918251 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release metoprolol 95 mg
Number of subjects: 65
Study 11918251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 9439530 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper supplementation (2 mg/d for 4 weeks)
Number of subjects: 20
Study 9439530 — intervention group
Group type: COMPARATOR
Intervention: Copper supplementation
Number of subjects: 20
Study 7513853 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem method
Number of subjects: 56
Study 7513853 — intervention group
Group type: COMPARATOR
Intervention: Simple sequential method
Number of subjects: 56
Study 3428132 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 100 mg/kg (max 4 g) intravenously (i.v.) once daily
Number of subjects: 30
Study 3428132 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin i.v. 160 mg/kg/day plus chloramphenicol i.v. 100 mg/kg/day every 6 h
Number of subjects: 30
Study 31325040 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat germ-enriched bread (6 g of wheat germ)
Number of subjects: 55
Study 31325040 — intervention group
Group type: COMPARATOR
Intervention: Non-enriched wheat bread
Number of subjects: 55
Study 28357972 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention for patient-caregiver dyads as part of home-based specialized palliative care (Domus model)
Number of subjects: 0
Study 28357972 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 0
Study 26024551 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate solution (CHO)
Number of subjects: 12
Study 26024551 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate and 4 mg/kg caffeine (C+C)
Number of subjects: 12
Study 26024551 — intervention group
Group type: COMPARATOR
Intervention: water (PLA)
Number of subjects: 12
Study 25288141 — intervention group
Group type: EXPERIMENTAL
Intervention: PAIR-UP intervention
Number of subjects: 638
Study 25288141 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 638
Study 23919853 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter and synchronous low dose intravaginal misoprostol
Number of subjects: 3
Study 23919853 — intervention group
Group type: COMPARATOR
Intervention: Foley catheter alone
Number of subjects: 3
Study 23919853 — intervention group
Group type: COMPARATOR
Intervention: Low dose intravaginal misoprostol alone
Number of subjects: 3
Study 21097434 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral State Index (CSI) during target controlled infusion (TCI) of propofol
Number of subjects: 40
Study 18443815 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity (MI) active recovery (60 W, approximately 35% VO(2max))
Number of subjects: 9
Study 18443815 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity (LI) active recovery (20 W, approximately 20% VO(2max))
Number of subjects: 9
Study 18443815 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 9
Study 16571641 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-HMG
Number of subjects: 184
Study 16571641 — intervention group
Group type: COMPARATOR
Intervention: rFSH
Number of subjects: 184
Study 12616007 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-DOTA
Number of subjects: 56
Study 12616007 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA
Number of subjects: 56
Study 10719590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (Zinnat, 2 x 250 mg/d)
Number of subjects: 202
Study 10719590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 8958492 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin 3%
Number of subjects: 7
Study 8958492 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch 6%
Number of subjects: 7
Study 1313467 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran diet (123 g oat bran for 4 weeks)
Number of subjects: 23
Study 1313467 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran diet (54 g wheat bran for 4 weeks)
Number of subjects: 23
Study 3997300 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine sulphate
Number of subjects: 6
Study 3997300 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin coadministration
Number of subjects: 6
Study 31730042 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (Run4Love)
Number of subjects: 300
Study 31730042 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 300
Study 28877566 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger capsules
Number of subjects: 49
Study 28877566 — intervention group
Group type: COMPARATOR
Intervention: Control (no ginger capsules)
Number of subjects: 49
Study 25185858 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated protein C (APC) with Topical Negative Pressure (TNP)
Number of subjects: 2
Study 25185858 — intervention group
Group type: COMPARATOR
Intervention: Topical Negative Pressure (TNP) alone
Number of subjects: 2
Study 25336571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 0
Study 25336571 — intervention group
Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 0
Study 22209257 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinomanometry after nasal decongestant (ND) xylometazoline
Number of subjects: 71
Study 22209257 — intervention group
Group type: COMPARATOR
Intervention: Rhinomanometry
Number of subjects: 71
Study 20138368 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 25 microg
Number of subjects: 125
Study 20138368 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 75 microg
Number of subjects: 125
Study 20138368 — intervention group
Group type: EXPERIMENTAL
Intervention: Microplasmin 125 microg
Number of subjects: 125
Study 20138368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 17951622 — intervention group
Group type: EXPERIMENTAL
Intervention: Early revascularization (ERV)
Number of subjects: 278
Study 17951622 — intervention group
Group type: COMPARATOR
Intervention: Initial medical stabilization (IMS)
Number of subjects: 278
Study 15338791 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg via Turbuhaler
Number of subjects: 17
Study 15338791 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 50 microg via Turbuhaler
Number of subjects: 17
Study 15338791 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg via Diskhaler
Number of subjects: 17
Study 15338791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11249979 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (31 patients) at a dose of 10 mg/kg once a week for 3 months
Number of subjects: 71
Study 11249979 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (40 patients) at a dose of 20 mg/kg per day for 3 months
Number of subjects: 71
Study 11249979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 71
Study 9660523 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine
Number of subjects: 402
Study 9660523 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine + Atenolol
Number of subjects: 402
Study 9660523 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine + Enalapril
Number of subjects: 402
Study 9660523 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine (after enalapril failure)
Number of subjects: 402
Study 9660523 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 402
Study 9660523 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 402
Study 7851352 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen sodium 1100 mg 1 h prior to surgery
Number of subjects: 180
Study 7851352 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen sodium 1100 mg immediately after surgery
Number of subjects: 180
Study 7851352 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 180
Study 2755866 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 70% dimethyl sulfoxide (DMSO)
Number of subjects: 84
Study 2755866 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% dimethyl sulfoxide (DMSO)
Number of subjects: 84
Study 2755866 — intervention group
Group type: COMPARATOR
Intervention: 0.85% normal saline (Control)
Number of subjects: 84
Study 341247 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunotherapy (75 mg of living BCG on a scratched area once a week)
Number of subjects: 39
Study 341247 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (control group)
Number of subjects: 39
Study 30665152 — intervention group
Group type: EXPERIMENTAL
Intervention: Relay model (Danish screening brief intervention and referral to treatment)
Number of subjects: 561
Study 30665152 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 561
Study 28843768 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib and dexamethasone
Number of subjects: 929
Study 28843768 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone
Number of subjects: 929
Study 26524801 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐FSH
Number of subjects: 45
Study 26524801 — intervention group
Group type: COMPARATOR
Intervention: hMG
Number of subjects: 45
Study 23607997 — intervention group
Group type: EXPERIMENTAL
Intervention: Fearless Dominance
Number of subjects: 0
Study 23607997 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Centered Impulsivity
Number of subjects: 0
Study 21332248 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 12262
Study 21332248 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 12262
Study 19836621 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 60
Study 19836621 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 60
Study 19836621 — intervention group
Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 60
Study 17602060 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (Avastin®) plus carboplatin and paclitaxel (BV/CP)
Number of subjects: 878
Study 17602060 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel alone (CP)
Number of subjects: 878
Study 16176400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SLIT for 1 year, followed by 2 years of active treatment
Number of subjects: 24
Study 16176400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SLIT for 2 years
Number of subjects: 24
Study 16176400 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SLIT for 3 years
Number of subjects: 24
Study 16176400 — intervention group
Group type: COMPARATOR
Intervention: Placebo SLIT for 1 year
Number of subjects: 24
Study 11961328 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total with the addition of 10% xylitol (Total‐Xylitol)
Number of subjects: 155
Study 11961328 — intervention group
Group type: COMPARATOR
Intervention: Colgate Total
Number of subjects: 155
Study 11961328 — intervention group
Group type: COMPARATOR
Intervention: Colgate Total without triclosan and without xylitol
Number of subjects: 155
Study 10412270 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl2 expression in euploid cases
Number of subjects: 114
Study 10412270 — intervention group
Group type: EXPERIMENTAL
Intervention: Bax expression in euploid cases
Number of subjects: 114
Study 10412270 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl2 expression in aneuploid cases
Number of subjects: 114